EyePoint Pharmaceuticals Inc (EYPT)
10.49
-0.27
(-2.51%)
USD |
NASDAQ |
Nov 14, 16:00
10.48
-0.01
(-0.10%)
After-Hours: 20:00
EyePoint Pharmaceuticals Total Return Level: 10.75 for Nov. 13, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
November 13, 2024 | 10.75 |
November 12, 2024 | 11.11 |
November 11, 2024 | 12.00 |
November 08, 2024 | 11.63 |
November 07, 2024 | 11.59 |
November 06, 2024 | 12.08 |
November 05, 2024 | 11.61 |
November 04, 2024 | 11.70 |
November 01, 2024 | 12.06 |
October 31, 2024 | 11.76 |
October 30, 2024 | 11.46 |
October 29, 2024 | 11.54 |
October 28, 2024 | 12.12 |
October 25, 2024 | 9.50 |
October 24, 2024 | 9.56 |
October 23, 2024 | 9.96 |
October 22, 2024 | 10.75 |
October 21, 2024 | 10.70 |
October 18, 2024 | 11.05 |
October 17, 2024 | 11.15 |
October 16, 2024 | 11.28 |
October 15, 2024 | 9.88 |
October 14, 2024 | 10.17 |
October 11, 2024 | 8.83 |
October 10, 2024 | 8.24 |
Date | Value |
---|---|
October 09, 2024 | 8.39 |
October 08, 2024 | 8.48 |
October 07, 2024 | 8.71 |
October 04, 2024 | 8.63 |
October 03, 2024 | 8.37 |
October 02, 2024 | 8.21 |
October 01, 2024 | 8.00 |
September 30, 2024 | 7.99 |
September 27, 2024 | 7.98 |
September 26, 2024 | 8.07 |
September 25, 2024 | 8.15 |
September 24, 2024 | 8.34 |
September 23, 2024 | 8.29 |
September 20, 2024 | 8.91 |
September 19, 2024 | 9.18 |
September 18, 2024 | 8.91 |
September 17, 2024 | 8.78 |
September 16, 2024 | 8.84 |
September 13, 2024 | 9.10 |
September 12, 2024 | 8.88 |
September 11, 2024 | 8.22 |
September 10, 2024 | 8.03 |
September 09, 2024 | 8.24 |
September 06, 2024 | 7.97 |
September 05, 2024 | 8.06 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
2.28
Minimum
Mar 24 2023
29.71
Maximum
Feb 12 2024
10.21
Average
9.302
Median
Mar 16 2020
Total Return Level Benchmarks
Cassava Sciences Inc | 44.19 |
Regeneron Pharmaceuticals Inc | 782.51 |
Adverum Biotechnologies Inc | 7.57 |
Regenxbio Inc | 10.68 |
Editas Medicine Inc | 2.96 |